Myxoid liposarcoma is a unique cancer as >95% of tumors contain a reciprocal chromosomal translocation, t(12;16)(q13;p11), which produces the chimeric fusion protein FUS-CHOP (also known as FUS-DDIT3) [4, 5]. This evidence concerns the gene FUS and myxoid liposarcoma.